Compare W W Grainger Inc (GWW) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
W W Grainger Inc vs Tenet Healthcare Corporation — how do they compare? W W Grainger Inc trades at $1,300.82 (market cap $61.32B), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.89B). The key difference: W W Grainger Inc is far larger — about 2.9× Tenet Healthcare Corporation's market cap, and W W Grainger Inc pays a 0.77% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| GWW | THC | |
|---|---|---|
Market Cap | $61.32B | $20.89B |
Sector | Technology | Health |
52-Week High | $1.40K | $262.63 |
52-Week Low | $918.18 | $161.37 |
Enterprise Value | $63.53B | $31.97B |
Dividend Yield | 0.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GWW trades at $1,277.55, down 0.39% on the day, amid a bearish technical signal. The stock has shown strong fundamental performance with Q2 2026 EPS beating estimates at $12.01 and revenue growth to $5.0 billion, leading to a raised full-year outlook. Analyst consensus is a Buy with a $1,310 price target, though technical indicators suggest near-term pressure with support at $1,270 and resistance at $1,290.
The outlook for GWW is positive based on earnings momentum and margin expansion, but risks include macroeconomic sensitivity and competitive pressures. The stock's high P/E of 33.07 indicates premium valuation, requiring sustained growth to justify current levels. Institutional sentiment remains cautious with a Hold-heavy rating distribution.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About W W Grainger Inc
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
